Get the Stockscreener App
8.5972
1.98%
0.1672
After Hours:
11.29
2.6928
+31.32%
Aclarion Inc stock is traded at $8.5972, with a volume of 2.68M.
It is up +1.98% in the last 24 hours and up +20.92% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$8.43
Open:
$8.79
24h Volume:
2.68M
Relative Volume:
180.67
Market Cap:
$5.01M
Revenue:
$49,300
Net Income/Loss:
$-6.27M
P/E Ratio:
-0.9458
EPS:
-9.09
Net Cash Flow:
$-5.38M
1W Performance:
+16.97%
1M Performance:
+20.92%
6M Performance:
+0.20%
1Y Performance:
+74.00%
1-Day Range:
$7.60
$8.7959
1-Week Range:
$7.4431
$9.00
52-Week Range:
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
8.5972 | 4.91M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
286.59 | 48.92B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
96.39 | 17.25B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
65.61 | 13.59B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
90.52 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.70 | 7.14B | 906.14M | -52.62M | 89.62M | -0.3621 |
Aclarion Inc Stock (ACON) Latest News
Can trapped investors hope for a rebound in Aclarion Inc.Weekly Investment Recap & Fast Gain Stock Trading Tips - newser.com
Why Aclarion Inc. stock attracts high net worth investors2025 Dividend Review & Weekly Setup with ROI Potential - newser.com
Published on: 2025-10-10 06:02:50 - newser.com
Live market analysis of Aclarion Inc. Equity WarrantWeekly Volume Report & Safe Capital Growth Trade Ideas - newser.com
Published on: 2025-10-10 05:09:35 - newser.com
What machine learning models say about Aclarion Inc. Equity WarrantTake Profit & Verified Momentum Stock Ideas - newser.com
Can Aclarion Inc. stock resist sector downturnsTrade Performance Summary & Verified High Yield Trade Plans - newser.com
Published on: 2025-10-10 04:04:21 - newser.com
Is Aclarion Inc. (IT20) stock cheap by valuation metricsMarket Performance Recap & Risk Controlled Swing Trade Alerts - newser.com
Is Aclarion Inc. Equity Warrant stock entering bullish territoryStock Surge & Long-Term Safe Investment Plans - newser.com
Published on: 2025-10-09 05:24:20 - newser.com
Aclarion to Present at the LD Micro Main Event XIX - The Globe and Mail
Oct 20, 12:00 PM PT: Aclarion to Present at LD Micro Main Event XIX in San Diego - Stock Titan
Is Aclarion Inc. (IT20) stock bottoming after sell off2025 EndofYear Setup & Community Consensus Stock Picks - newser.com
Can Aclarion Inc. Equity Warrant stock maintain operating marginsJuly 2025 Price Swings & Capital Efficient Trade Techniques - newser.com
Chart based exit strategy for Aclarion Inc.Portfolio Update Summary & Low Drawdown Trading Strategies - newser.com
Evaluating Aclarion Inc. with trendline analysis2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com
Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH - markets.businessinsider.com
Aclarion, Inc. Named Finalist in 2025 Digital Health Awards for Nociscan Technology - Quiver Quantitative
Finalist: 2025 Digital Health Awards — Aclarion's Nociscan honored in Rising Star clinical device category - Stock Titan
Evaluating Aclarion Inc. Equity Warrant with trendline analysisGDP Growth & Daily Entry Point Trade Alerts - newser.com
Is Aclarion Inc. Equity Warrant reversing from oversold territoryShare Buyback & Verified Momentum Stock Watchlist - newser.com
Will Aclarion Inc. Equity Warrant stock recover after recent dropMarket Activity Recap & Target Return Focused Stock Picks - newser.com
Real time breakdown of Aclarion Inc. stock performance2025 Pullback Review & Expert Curated Trade Ideas - newser.com
Why Aclarion Inc. stock could see breakout soonGap Up & Reliable Entry Point Trade Alerts - newser.com
Using data filters to optimize entry into Aclarion Inc.Quarterly Trade Summary & Step-by-Step Trade Execution Guides - newser.com
How to build a custom watchlist for Aclarion Inc. Equity WarrantJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
How to forecast Aclarion Inc. trends using time seriesChart Signals & Daily Entry Point Alerts - newser.com
What data driven models say about Aclarion Inc. Equity Warrant’s futureVolume Spike & Fast Moving Stock Watchlists - newser.com
Real time social sentiment graph for Aclarion Inc.Portfolio Risk Summary & Reliable Price Action Trade Plans - newser.com
Key metrics from Aclarion Inc.’s quarterly dataCEO Change & Smart Money Movement Alerts - newser.com
Is now a turning point for Aclarion Inc.Weekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com
How geopolitical risks impact Aclarion Inc. (IT20) stock2025 Volatility Report & Weekly Top Gainers Trade List - newser.com
Is Aclarion Inc. stock reversal real or fakeJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Can Aclarion Inc. (IT20) stock deliver double digit returns2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com
Tools to assess Aclarion Inc.’s risk profileMarket Rally & Low Drawdown Investment Ideas - newser.com
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.35%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):